Immuron (IMRN) Change in Accured Expenses (2022)

Immuron (IMRN) recorded quarterly Change in Accured Expenses of $204577.7 in Q2 2022.

Immuron (IMRN) Change in Accured Expenses (2022) Analysis & Trends

Immuron's Change in Accured Expenses history runs 1 years deep, the most recent figure standing at $204577.7 for Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Accured Expenses (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	931,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	644,700.00
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	70.50 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Immuron	921.61 Mn	921.58 Mn	-	-

Download Data

Date	Value
Jun 30, 2022	204,577.69
Jun 30, 2022	204,577.69